215 related articles for article (PubMed ID: 34291358)
41. Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.
Wang C; Tang K; Li Z; Chen Z; Xu H; Ye Z
Urol Oncol; 2016 Feb; 34(2):59.e23-34. PubMed ID: 26421587
[TBL] [Abstract][Full Text] [Related]
42. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells.
Mandal S; Davie JR
J Cell Physiol; 2010 Jul; 224(1):28-32. PubMed ID: 20301197
[TBL] [Abstract][Full Text] [Related]
43. Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells.
Faouzi M; Hague F; Potier M; Ahidouch A; Sevestre H; Ouadid-Ahidouch H
J Cell Physiol; 2011 Feb; 226(2):542-51. PubMed ID: 20683915
[TBL] [Abstract][Full Text] [Related]
44. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer.
Chan DW; Liu VW; To RM; Chiu PM; Lee WY; Yao KM; Cheung AN; Ngan HY
Br J Cancer; 2009 Oct; 101(8):1433-43. PubMed ID: 19755996
[TBL] [Abstract][Full Text] [Related]
46. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
Lo PK; Lee JS; Sukumar S
Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
48. Downregulation of Msi1 suppresses the growth of human colon cancer by targeting p21cip1.
Gao C; Han C; Yu Q; Guan Y; Li N; Zhou J; Tian Y; Zhang Y
Int J Oncol; 2015 Feb; 46(2):732-40. PubMed ID: 25394506
[TBL] [Abstract][Full Text] [Related]
49. Fluorizoline Blocks the Interaction between Prohibitin-2 and
Takagi H; Moyama C; Taniguchi K; Ando K; Matsuda R; Ando S; Ii H; Kageyama S; Kawauchi A; Chouha N; Désaubry L; Nakata S
Mol Pharmacol; 2022 Feb; 101(2):78-86. PubMed ID: 34862308
[TBL] [Abstract][Full Text] [Related]
50. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
[TBL] [Abstract][Full Text] [Related]
51. Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells.
Mandriota SJ; Buser R; Lesne L; Stouder C; Favaudon V; Maechler P; Béna F; Clément V; Rüegg C; Montesano R; Sappino AP
J Biol Chem; 2010 Apr; 285(17):13092-106. PubMed ID: 20177072
[TBL] [Abstract][Full Text] [Related]
52. Constitutively active ErbB2 regulates cisplatin-induced cell death in breast cancer cells via pro- and antiapoptotic mechanisms.
Sigurðsson HH; Olesen CW; Dybboe R; Lauritzen G; Pedersen SF
Mol Cancer Res; 2015 Jan; 13(1):63-77. PubMed ID: 25143433
[TBL] [Abstract][Full Text] [Related]
53. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
54. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
55. 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1).
Huang J; Yang G; Huang Y; Kong W; Zhang S
Mol Med Rep; 2016 Feb; 13(2):1373-80. PubMed ID: 26676829
[TBL] [Abstract][Full Text] [Related]
56. Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis: correlation with nuclear β-catenin.
Femia AP; Dolara P; Salvadori M; Caderni G
BMC Cancer; 2013 Feb; 13():48. PubMed ID: 23374535
[TBL] [Abstract][Full Text] [Related]
57. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
58. MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G₁/S transition and apoptosis by targeting p21(WAF1/CIP1).
Wang H; Zhu LJ; Yang YC; Wang ZX; Wang R
Br J Cancer; 2014 Jul; 111(2):339-54. PubMed ID: 24921914
[TBL] [Abstract][Full Text] [Related]
59. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
60. RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer.
Sun X; Hu Y; Wu J; Shi L; Zhu L; Xi PW; Wei JF; Ding Q
J Exp Clin Cancer Res; 2018 Dec; 37(1):298. PubMed ID: 30514345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
